ALDOMET 250 mg, coated tablet 30 tablets
Active ingredients: Anhydrous methyldopa, Methyldopa sesquihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALDOMET 250 mg, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- HAC PHARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 May 1964
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60578560CIP73002198CIP133400930021989Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHYLDOPA SESQUIHYDRATÉcomprimé | 282,5 mg · un comprimé | SA |
| MÉTHYLDOPA ANHYDREcomprimé | 250,0 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.